Company Profile:
SYNGENE INTERNATIONAL LIMITED UNIT VI Company Profile
Company Type: Factory
Syngene International Limited Unit VI is an operational site belonging to Syngene International Limited, a leading integrated research, development, and manufacturing organization (CRDMO) based in India. This unit functions as a facility for carrying out various scientific and manufacturing activities.
Syngene provides comprehensive discovery, development, and manufacturing services for novel molecular entities across a range of therapeutic areas. Their capabilities span from early-stage discovery research to clinical development and commercial manufacturing of small molecules, biologics, and other advanced therapies. As a CRDMO, Syngene operates state-of-the-art laboratories and manufacturing plants, making Unit VI a part of their production and service delivery infrastructure. It is involved in the actual execution of research projects, process development, and manufacturing operations for their global clientele.
Enterprise Products
Syngene International Limited Unit VI, as part of Syngene International Limited, functions as a Contract Research, Development, and Manufacturing Organization (CRDMO). The company does not typically produce or sell finished consumer products under its own brand. Instead, it provides a comprehensive range of scientific services to pharmaceutical, biotechnology, nutrition, animal health, and specialty chemical companies globally. These services are what they "produce" in terms of research outputs, developed compounds, and manufactured materials, and what they "sell" as their core business offerings.
Their primary service offerings, which can be considered their "products" in a business context, include:
Discovery Services:
Target identification and validation
Hit identification and lead generation
Medicinal chemistry and computational chemistry
In vitro and in vivo pharmacology studies
ADME (Absorption, Distribution, Metabolism, Excretion) and DMPK (Drug Metabolism and Pharmacokinetics) studies
Development Services:
Process chemistry and scale up for Active Pharmaceutical Ingredients (APIs)
Analytical development and validation
Formulation development for various dosage forms (e.g., oral solids, liquids, injectables)
Preclinical and clinical trial material (CTM) manufacturing
Toxicology and safety assessment studies
Manufacturing Services:
Active Pharmaceutical Ingredient (API) manufacturing for small molecules
Drug product manufacturing for small molecules
Biologics manufacturing (including mammalian and microbial systems)
Antibody Drug Conjugates (ADC) manufacturing
Biologics Services:
Cell line development
Upstream and downstream process development
Analytical characterization and bioassays for biologics
Clinical and commercial manufacturing of biologics